This bill establishes stringent conditions for employment and work arrangements at the Food and Drug Administration (FDA) to safeguard the security of drugs and devices. It explicitly prohibits any individual who is a national of a foreign country of concern , defined as China, Russia, or Iran, from being employed by or performing services for the FDA. Furthermore, any FDA employee or worker with an immediate family member who is a national of such a country must report this information, with failure to do so resulting in immediate termination of employment. The legislation also imposes a significant limitation on subsequent employment for former FDA personnel. For a 10-year period after leaving the FDA, individuals are barred from working for or performing services for any entity based in a foreign country of concern, a condition that applies to both existing and new employees. Moreover, employees involved in drug or device application review will have their access to certain FDA data restricted if they have immediate family ties to a foreign country of concern or previously worked for an entity based in one of these nations.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
American Medicine Safety and Security Act
USA119th CongressS-2986| Senate
| Updated: 10/8/2025
This bill establishes stringent conditions for employment and work arrangements at the Food and Drug Administration (FDA) to safeguard the security of drugs and devices. It explicitly prohibits any individual who is a national of a foreign country of concern , defined as China, Russia, or Iran, from being employed by or performing services for the FDA. Furthermore, any FDA employee or worker with an immediate family member who is a national of such a country must report this information, with failure to do so resulting in immediate termination of employment. The legislation also imposes a significant limitation on subsequent employment for former FDA personnel. For a 10-year period after leaving the FDA, individuals are barred from working for or performing services for any entity based in a foreign country of concern, a condition that applies to both existing and new employees. Moreover, employees involved in drug or device application review will have their access to certain FDA data restricted if they have immediate family ties to a foreign country of concern or previously worked for an entity based in one of these nations.